New AI tool promises faster vaccine development by predicting T cell epitopes

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell vaccine candidates.

Can At-Home Vision Tests Detect Active Neovascular AMD?

Three at-home vision-monitoring tools failed to detect worsening neovascular age-related macular degeneration (AMD), a diagnostic-test accuracy study reported. The paper-based KeepSight Journal from the International

May 3, 2024

CLN-619 by Cullinan Therapeutics for Refractory Multiple Myeloma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

January 6, 2025

AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval

Share this article COPD is a heterogeneous, progressive lung disease characterised by chronic symptoms such as cough and dyspnea. Credit: voronaman via Shutterstock. AstraZeneca has

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.